Par Pharmaceutical ( PRX), a maker of generic drugs, said that it entered into a supply and distribution agreement with AstraZeneca in the U.S. to distribute metoprolol succinate extended release tablets, which is substitutable for AstraZeneca's TOPROL-XL extended release tablets.

The New Jersey-based company began shipping metoprolol succinate extended release 25 mg tablets Tuesday.

TOPROL-XL is a beta1-selective (cardioselective) adrenoceptor-blocking agent, for oral administration, available as extended release tablets, the company said.

This story was created through a joint venture between TheStreet.com and IRIS.

More from Stocks

Video: Shark Tank Star Kevin O'Leary on Netflix, Amazon and Trade Worries

Video: Shark Tank Star Kevin O'Leary on Netflix, Amazon and Trade Worries

Bank of America Up 3.9% on Earnings Beat, But Analysts See Even More Gains Ahead

Bank of America Up 3.9% on Earnings Beat, But Analysts See Even More Gains Ahead

Here's How Shark Tank Star Kevin O'Leary Decides What Stocks to Invest In

Here's How Shark Tank Star Kevin O'Leary Decides What Stocks to Invest In

Dow Rises Slightly, Netflix Trades Higher Ahead of Earnings

Dow Rises Slightly, Netflix Trades Higher Ahead of Earnings

Russia Hacking Issue Makes Cybersecurity Stocks Look Like a Great Buy

Russia Hacking Issue Makes Cybersecurity Stocks Look Like a Great Buy